Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$10.08 - $17.46 $68,352 - $118,396
6,781 New
6,781 $118,000
Q4 2022

Feb 07, 2023

SELL
$40.77 - $53.73 $1,223 - $1,611
-30 Reduced 0.44%
6,781 $315,000
Q3 2022

Nov 08, 2022

SELL
$48.29 - $71.27 $90,302 - $133,274
-1,870 Reduced 21.54%
6,811 $353,000
Q2 2022

Aug 05, 2022

SELL
$38.13 - $76.93 $154,807 - $312,335
-4,060 Reduced 31.87%
8,681 $410,000
Q1 2022

May 06, 2022

SELL
$56.06 - $74.11 $151,922 - $200,838
-2,710 Reduced 17.54%
12,741 $907,000
Q4 2021

Feb 08, 2022

SELL
$60.19 - $97.37 $36,595 - $59,200
-608 Reduced 3.79%
15,451 $1.16 Million
Q3 2021

Nov 08, 2021

BUY
$41.02 - $58.65 $9,024 - $12,903
220 Added 1.39%
16,059 $912,000
Q2 2021

Aug 10, 2021

BUY
$43.76 - $53.11 $281,376 - $341,497
6,430 Added 68.34%
15,839 $697,000
Q4 2020

Feb 08, 2021

SELL
$41.16 - $47.47 $14,405 - $16,614
-350 Reduced 3.59%
9,409 $396,000
Q3 2020

Nov 09, 2020

SELL
$43.36 - $53.53 $37,636 - $46,464
-868 Reduced 8.17%
9,759 $447,000
Q2 2020

Aug 07, 2020

BUY
$46.37 - $57.58 $64,361 - $79,921
1,388 Added 15.02%
10,627 $534,000
Q4 2019

Feb 03, 2020

SELL
$57.95 - $66.61 $6,954 - $7,993
-120 Reduced 1.28%
9,239 $571,000
Q2 2019

Aug 05, 2019

BUY
$81.3 - $97.35 $50,406 - $60,357
620 Added 7.09%
9,359 $790,000
Q1 2019

May 03, 2019

SELL
$69.08 - $105.66 $7,598 - $11,622
-110 Reduced 1.24%
8,739 $835,000
Q2 2018

Aug 06, 2018

BUY
$81.85 - $120.51 $52,384 - $77,126
640 Added 7.8%
8,849 $1.03 Million
Q1 2018

May 04, 2018

SELL
$57.91 - $92.15 $462,353 - $735,725
-7,984 Reduced 49.31%
8,209 $664,000
Q4 2017

Feb 01, 2018

BUY
$45.65 - $59.37 $460,882 - $599,399
10,096 Added 165.59%
16,193 $950,000
Q3 2017

Oct 31, 2017

BUY
$37.91 - $46.8 $231,137 - $285,339
6,097
6,097 $285,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $109M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.